CTLA4IG (BMS-188667) in a phase IIB, multi-center, randomized, double-blind, placebo controlled study in rheumatoid arthritis patients receiving etanercept: Association between clinical response and key biomarkers Annual European Congress of Rheumatology Schiff, M., Genovese, M., Nuamah, I., Becker, J., Weinblatt, M. BMJ PUBLISHING GROUP. 2003: 178–178

View details for Web of Science ID 000224551400565